Contribution of the Purinergic Receptor P2X7 to Development of Lung Immunopathology during Influenza Virus Infection.
about
Purinergic Signalling: Therapeutic Developments.The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression.The P2X7 Receptor in Inflammatory Diseases: Angel or Demon?Purinergic Regulation of Neutrophil Function.ATP/P2X7 receptor signaling as a potential anti-inflammatory target of natural polyphenols
P2860
Contribution of the Purinergic Receptor P2X7 to Development of Lung Immunopathology during Influenza Virus Infection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Contribution of the Purinergic ...... ing Influenza Virus Infection.
@en
Contribution of the Purinergic ...... ing Influenza Virus Infection.
@nl
type
label
Contribution of the Purinergic ...... ing Influenza Virus Infection.
@en
Contribution of the Purinergic ...... ing Influenza Virus Infection.
@nl
prefLabel
Contribution of the Purinergic ...... ing Influenza Virus Infection.
@en
Contribution of the Purinergic ...... ing Influenza Virus Infection.
@nl
P2093
P2860
P356
P1433
P1476
Contribution of the Purinergic ...... ing Influenza Virus Infection.
@en
P2093
Adolfo García-Sastre
Jean K Lim
Ma G Gonzalez
Megan E Ermler
Michael Schotsaert
Virginia Gillespie
P2860
P356
10.1128/MBIO.00229-17
P577
2017-03-28T00:00:00Z